NCT05241847

Brief Summary

This study uses a smartphone application/web interface (RealTime Clinic; RTC) to collect patient and parent reports of a pediatric liver transplant recipient's quality of life (QOL), and examines the extent to which QOL evaluations can be integrated into care with the help of the application. The QOL measure that is used in this study is the Pediatric Liver Transplant Quality of Life (PeLTQL) questionnaire. Utilization, effectiveness, and efficiency data are evaluated. Hypotheses are fully described in the protocol. The primary hypothesis is that 80% of recruited child-proxy dyads will have at least one RTC-enabled PeLTQL score at 12 months. Other hypotheses look at implementation metrics and patient outcomes.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2022

Longer than P75 for not_applicable

Geographic Reach
2 countries

7 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 22, 2022

Completed
25 days until next milestone

First Posted

Study publicly available on registry

February 16, 2022

Completed
12 days until next milestone

Study Start

First participant enrolled

February 28, 2022

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 20, 2024

Completed
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2025

Completed
Last Updated

January 8, 2026

Status Verified

January 1, 2026

Enrollment Period

2.1 years

First QC Date

January 22, 2022

Last Update Submit

January 6, 2026

Conditions

Keywords

quality of life

Outcome Measures

Primary Outcomes (1)

  • Implementation metric

    The proportion of participants who complete the Pediatric Liver Transplant Quality of Life (PeLTQL) measure (either parent or child), at least once

    12 months

Secondary Outcomes (9)

  • Patient baseline quality of life (child report on PeLTQL)

    Time of enrollment

  • Patient quality of life (child report on PeLTQL)

    12 months post-enrollment

  • Proxy report of child's quality of life using PeLTQL

    Time of enrollment

  • Proxy report of child's quality of life using PeLTQL

    12 months post-enrollment

  • Medication level variability index (MLVI)

    Calculated for year following implementation (12 month period following enrollment)

  • +4 more secondary outcomes

Other Outcomes (1)

  • Rejection

    24 months

Study Arms (1)

Pediatric liver transplant recipients

EXPERIMENTAL

As this is a single arm trial, all eligible liver transplant recipients and their caregivers will be enrolled in this arm. Eligible participants are children who received a liver transplant at least 1 year prior to enrollment at a participating SNEPT center and continue to receive their post-transplant care at that center.

Behavioral: PeLTQL delivery via electronic means

Interventions

Delivery of PeLTQL scoring information to clinicians via electronic means.

Also known as: Real Time Clinic mobile application
Pediatric liver transplant recipients

Eligibility Criteria

Age8 Years - 20 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • The patient must meet all of below criteria to be eligible for enrollment in the study:
  • The patient is \> 8 at enrollment and \< 20 years of age at 2 year post enrollment.
  • The patient received a liver transplantation at least 1 year prior to enrollment.
  • The patient and parent/ guardian have internet access either through a smartphone, tablet or computer.
  • The patient and at least one guardian speaks English or Spanish at a level that allows them to understand the study procedures and consent to the study.

You may not qualify if:

  • None of the following may be present if the patient is to be eligible for enrollment in the study:
  • The patient is expected to transition to another service (e.g., adult clinic, another hospital) in the year following enrollment.
  • The guardian or patient (in a developmentally-appropriate manner) do not understand the study procedures. This will be verified by asking both guardian and adolescent to repeat the study procedures.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (7)

UCSF Benioff Children's Hospital

Oakland, California, 94609, United States

Location

Emory Children's

Atlanta, Georgia, 30322, United States

Location

Columbia University Children's

New York, New York, 10027, United States

Location

Mt. Sinai

New York, New York, 10029, United States

Location

UPMC Children's

Pittsburgh, Pennsylvania, 15224, United States

Location

Seattle Children's

Seattle, Washington, 98105, United States

Location

Toronto Sick Kids

Toronto, Ontario, 10001, Canada

Location

Related Publications (1)

  • Ng V, Nicholas D, Dhawan A, Yazigi N, Ee L, Stormon M, Gilmour S, Schreiber R, Taylor R, Otley A; PeLTQL study group. Development and validation of the pediatric liver transplantation quality of life: a disease-specific quality of life measure for pediatric liver transplant recipients. J Pediatr. 2014 Sep;165(3):547-55.e7. doi: 10.1016/j.jpeds.2014.05.024. Epub 2014 Jun 26.

    PMID: 24976329BACKGROUND

Related Links

MeSH Terms

Conditions

Child BehaviorAdolescent Behavior

Condition Hierarchy (Ancestors)

Behavior

Study Officials

  • Eyal Shemesh, MD

    Icahn School of Medicine at Mt. Sinai

    PRINCIPAL INVESTIGATOR
  • George Mazariegos, MD

    University of Pittsburgh

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Model Details: Single arm interventional trial with use of the RTC mobile application representing the intervention of interest
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Surgery, Chief Pediatric Transplantation

Study Record Dates

First Submitted

January 22, 2022

First Posted

February 16, 2022

Study Start

February 28, 2022

Primary Completion

March 20, 2024

Study Completion

July 30, 2025

Last Updated

January 8, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations